1 - 1 / 1 1 |
1. Brain-selective mTOR inhibitors as potential therapeutics for glioblastoma multiforme Rose M. Sheridan, Matthew Alan Gregory, Hrvoje Petković, Sabine Gaisser, Rachel E. Lill, Michael J. Ward, Andrew L. Kaja, Christoph H. Beckman, Iain R. Challis, Steven J. Moss, Barrie Wilkinson, Peter Houghton, Ming-Qiang Zhang, 2006, published scientific conference contribution abstract Keywords: rapamicin, mTOR, protirakasti preparati, antikancerogeni preparati |